Accessibility help Skip to navigation Skip to content Skip to footer

Cookies on FT Sites

We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Manage cookies
Accept & continue
  • Sign In
  • Subscribe
Open drawer menu Open search bar
Financial Times
myFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • Americas
    • Middle East and North Africa
    Most Read
    • Iran’s top military leader Qassem Soleimani killed in US air strike
    • Soleimani assassination risks all-out war between US and Iran
    • Interpol issues ‘red notice’ for Carlos Ghosn as Turkey detains 7
    • Qassem Soleimani, Iranian military commander, 1957-2020
    • Wealthy Indians count the cost as they say ‘I do’
  • US
    Sections
    • US Home
    • US Economy
    • US Politics & Policy
    • US Companies
    Most Read
    • Iran’s top military leader Qassem Soleimani killed in US air strike
    • Soleimani assassination risks all-out war between US and Iran
    • US to deploy 3,500 new troops to Middle East — as it happened
    • Qassem Soleimani, Iranian military commander, 1957-2020
    • Donald Trump says US not seeking war with Iran by killing Soleimani
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Turkish jet company blames rogue employee for Ghosn escape
    • Entrepreneur builds an aircraft ‘boneyard’ in centre of Australia
    • Manhattan property decline worsened as Wall Street boomed
    • Ten people set to shape Wall Street in 2020
    • Russian billionaire Alisher Usmanov eyes stake in Everton
  • Tech
  • Markets
    Sections
    • Markets Home
    • fastFT
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    Most Read
    • Wall Street hits record high as PBoC stimulus boosts global stocks
    • Time for investors to rethink government bonds
    • Pound falls as traders set for year of tricky Brexit talks
    • How investors see 2020 shaping up in US financial markets
    • European Central Bank has one item left in its toolkit: dual rates
  • Graphics
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Instant Insight
    • Lex
    • Alphaville
    • Obituaries
    • Letters
    Most Read
    • Soleimani assassination risks all-out war between US and Iran
    • The hijacking of Edinburgh’s Hogmanay
    • Active fund managers pray for turnround as exodus continues
    • US-China financial war is just beginning to take shape
    • America must be ready for Iranian retaliation
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • What do I do if I fail to get into Oxbridge?
    • Start-ups can benefit from moneyed tech enthusiasts as patrons
    • The Dominic Cummings guide to management
    • Quitting to set up on your own is risky and rewarding
    • The start-ups on a mission to reduce food waste
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • HMRC to act over state pension ‘missing years’
    • Alisher Usmanov: ‘I was never what you could call an oligarch’
    • Science: what breakthroughs will the 2020s bring?
    • Making a will: 10 things you should know
    • How to be healthy in London
  • How to Spend It
  • Sign In
  • Subscribe
  1. Companies
  2. Health
  • Health Care
  • Pharmaceuticals
Menu Search
  • Home
  • World
  • US
  • Companies
  • Tech
  • Markets
  • Graphics
  • Opinion
  • Work & Careers
  • Life & Arts
  • How to Spend It
Financial Times
  • Sign In
  • Subscribe

Get a fresh start.

Get a fresh start.
Choose your FT trial

Health sector

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Friday, 3 January, 2020
    Drug prices
    Pfizer and other drugmakers start 2020 with price rises

    Average 6% increase is less than in previous years as industry faces political pressure

  • Friday, 3 January, 2020
    Pharmaceuticals sector
    Illumina and Pacific Biosciences call off merger

    Mooted $1.2bn deal halted after scrutiny by UK and US competition watchdogs

  • Friday, 3 January, 2020
    AnalysisTobacco
    Are the UK’s rules on e-cigarettes too lax?

    Over 20 countries have banned vaping but it is seen as much safer than tobacco in the UK

  • Thursday, 2 January, 2020
    Tobacco
    US health officials unveil e-cigarette restrictions

    Critics complain policy targeting some flavoured cartridges does not go far enough

  • Wednesday, 1 January, 2020
    Google Inc
    Google AI system beats doctors in breast cancer tests

    Algorithm reduces both false positives and false negatives

  • Wednesday, 1 January, 2020
    LexDigital health
    Femtech: a fertile area  Premium

    Innovation: health and fitness devices and tracking apps could lift the underinvested sector

  • Wednesday, 1 January, 2020
    Lex
    ADHD app: game theory Premium

    Akili Interactive is one of a new crop of companies making video games to treat behavioural disorders

  • Wednesday, 1 January, 2020
    LexBiotech
    Synthetic spider silk: positive spin Premium

    Innovation: bioengineering the stuff makes spidey sense

  • Wednesday, 1 January, 2020
    AnalysisSingapore
    Asian countries watch as Singapore expands ‘war on diabetes’

    Absolute advertising ban proposed on high-sugar drinks as part of fight against disease

  • Promoted Content
  • Tuesday, 31 December, 2019
    AnalysisChinese society
    Celebrity doctor pay exposes China’s healthcare gap

    Wage disparities highlight unequal access to good quality medical treatment 

  • Monday, 30 December, 2019
    Chinese society
    Gene-editing scientist jailed in China

    Creator of the world’s first genetically modified twins handed three-year sentence

  • Sunday, 29 December, 2019
    National Health Service
    Yeovil hospital offers hope for UK’s stretched NHS

    Medical staff say shift in approach will help them weather winter crisis

  • Friday, 27 December, 2019
    Camilla Cavendish
    Prevention is always better than cure

    Healthcare professionals have a lot to learn from the economics of loss aversion

  • Friday, 27 December, 2019
    Anjana Ahuja
    Crossing ethical red lines in gene editing

    There is more support for genome alteration for serious diseases than for ‘enhancement’

  • Monday, 23 December, 2019
    NMC Health PLC
    NMC Health to launch review after Muddy Waters attack

    Shares in Abu Dhabi-based healthcare group soar as it seeks to reassure investors

  • Saturday, 21 December, 2019
    LexPharmaceuticals sector
    Extinction/Chinese medicine: diseconomies of scales Premium

    China’s $60bn traditional medicine industry threatens wildlife and offers poor returns

  • Friday, 20 December, 2019
    AnalysisNMC Health PLC
    NMC held talks to raise €200m in off-balance sheet debt

    Healthcare group under pressure from short-sellers over scale of borrowing

  • Friday, 20 December, 2019
    Australia
    Wildfire smoke threatens Sydney’s outdoor lifestyle

    Australian city could be choked for months with toxic air from rampant forest blazes

  • Thursday, 19 December, 2019
    Health Care
    NMC launches rebuttal against Muddy Waters report

    Healthcare group makes its case against short seller after shares drop almost a third

  • Wednesday, 18 December, 2019
    Drug prices
    White House lays out plan to import drugs from Canada

    Trump plan focuses on campaign issue while decrying impeachment

  • Wednesday, 18 December, 2019
    UK labour disputes
    Northern Ireland’s nurses go on strike

    Around 9,000 healthcare staff walked off the job over pay and patient safety

  • Wednesday, 18 December, 2019
    NMC Health PLC
    NMC hits back at ‘baseless’ Muddy Waters report

    Attack by short seller wiped almost £2bn off value of healthcare group

  • Wednesday, 18 December, 2019
    Cigna Corp
    New York Life agrees $6bn-plus deal for Cigna unit

    Takeover to provide cash injection to debt-laden insurer

  • Tuesday, 17 December, 2019
    NMC Health PLC
    NMC shares plunge after Muddy Waters attack

    Short seller raises ‘serious doubts’ about healthcare operator’s financial statements

  • Tuesday, 17 December, 2019
    US opioid epidemic
    Sacklers withdrew $10bn from Purdue during past decade

    Some states have targeted family members in opioid lawsuits after company bankruptcy

Previous You are on page 1 Next

Topics related to Health & pharmaceuticals

Useful links

Support

View Site Tips Help Centre About Us Accessibility myFT Tour Careers

Legal & Privacy

Terms & Conditions Privacy Cookies Copyright Slavery Statement & Policies

Services

FT Live Share News Tips Securely Individual Subscriptions Group Subscriptions Republishing Contracts & Tenders
Executive Job Search Advertise with the FT Follow the FT on Twitter FT Transact Secondary Schools

Tools

Portfolio Today's Newspaper (ePaper) Alerts Hub MBA Rankings
Enterprise Tools News feed Newsletters Currency Converter
More from the FT Group
Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2020. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

International Edition

  • Switch to UK Edition
  • Top sections
  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • Americas
    • Middle East and North Africa
  • US
    • US Economy
    • US Politics & Policy
    • US Companies
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • fastFT
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
  • Graphics
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Instant Insight
    • Lex
    • Alphaville
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • How to Spend It
  • Special Reports
  • FT recommends
  • Lex
  • Alphaville
  • EM Squared
  • Lunch with the FT
  • FT Globetrotter
  • Tech Scroll Asia
  • Moral Money
  • FTfm
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In